Key Points
Mucosal Melanoma of the head and neck has a very poor prognosis. Structured treatment directed at these malignancies remains variable due to low incidence of disease. Surgery, radiotherapy, and chemotherapy remain the mainstay of treatment. With limited literature, Immunotherapy demonstrates a promising aspect of treatment in prolonging survival rates in these malignancies. Further trials are necessary to prove efficiency of immunotherapy.